会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 81. 发明申请
    • Systems and methods for controlling production quantities
    • 控制生产数量的系统和方法
    • US20080104413A1
    • 2008-05-01
    • US11977885
    • 2007-10-26
    • Jeffrey BrunetIan CollinsYousuf ChowdharyAlex LemelevValeriy Kusov
    • Jeffrey BrunetIan CollinsYousuf ChowdharyAlex LemelevValeriy Kusov
    • H04L9/00
    • G06Q10/087G06Q10/06G06Q50/04Y02P90/30
    • Systems and methods are provided for controlling the number of products produced by contract manufacturers in order to prevent unauthorized overproduction. Each authorized device that is produced includes both a serial number and an encryption of the serial number. Each device is configured to decrypt the encrypted serial number and verify the decrypted serial number matches the serial number before the device will function properly. The encryption of the serial number is performed at a secure location outside of the control of the manufacturer, and the encrypted serial number is then transmitted to the manufacturer and stored to the device. Without knowledge of, or access to, the details of the encryption process, the manufacturer cannot independently produce devices with properly encrypted serial numbers. Accordingly, the number of properly functioning devices the manufacturer can produce can be limited by controlling the number of encrypted serial numbers provided to the manufacturer.
    • 提供系统和方法来控制合同制造商生产的产品数量,以防止未经授权的过度生产。 生产的每个授权设备都包括序列号和序列号的加密。 每个设备都配置为对加密的序列号进行解密,并在设备正常工作之前验证解密的序列号与序列号匹配。 序列号的加密在制造商的控制之外的安全位置执行,然后将加密的序列号发送到制造商并存储到设备中。 不知道或访问加密过程的细节,制造商不能独立地生产具有正确加密序列号的设备。 因此,制造商可以产生的正常功能的设备的数量可以通过控制提供给制造商的加密序列号的数量来限制。
    • 83. 发明申请
    • Multiple node junction structure
    • 多节点结结构
    • US20070125033A1
    • 2007-06-07
    • US11487113
    • 2006-07-14
    • Soeren StephanIan Collins
    • Soeren StephanIan Collins
    • E04B7/08E04H12/00
    • E04B1/32E04B2001/3247E04B2001/3294
    • Multiple node junctions have at least two nodes sharing an axis. Each node includes a node adaptor-mounting-surface at an angle Θ relative to the axis. An adaptor mounted to each node at the angle Θ relative to the axis uses an adaptor node-mounting-surface and at least one adaptor beam-mounting-surface. A beam having one or more adaptor-mounting-surfaces is mounted to the adaptors using beam adaptor-mounting-surfaces so that the beam is mounted at the angle Θ relative to the axis. The length of each adaptor corresponds to the spacing between each adaptor node-mounting-surface and its matching adaptor beam-mounting-surface. The lengths of the first and second adaptors are selected to accommodate the angle Θ. A framework, for example a free form glass wall or the like, can be created using a plurality of multiple node junctions according to embodiments of the present invention.
    • 多个节点具有至少两个共享一个轴的节点。 每个节点包括一个相对于轴的角度角的节点适配器安装表面。 以相对于轴的角度的角度安装到每个节点的适配器使用适配器节点安装表面和至少一个适配器梁安装表面。 具有一个或多个适配器安装表面的梁使用光束适配器安装表面安装到适配器,使得光束相对于轴以角度θta安装。 每个适配器的长度对应于每个适配器节点安装表面与其匹配的适配器梁安装表面之间的间距。 选择第一和第二适配器的长度以适应角度θ。 可以使用根据本发明的实施例的多个多节点连接来创建框架,例如自由形式的玻璃壁等。
    • 84. 发明申请
    • Systems and methods for automated diagnosis and repair of storage devices
    • 存储设备自动诊断和修复的系统和方法
    • US20070124130A1
    • 2007-05-31
    • US11699877
    • 2007-01-29
    • Jeffrey BrunetIan CollinsYousuf ChowdharyEric Li
    • Jeffrey BrunetIan CollinsYousuf ChowdharyEric Li
    • G06F9/455
    • G06F11/261
    • A peripheral electronic device includes a health check application configured to execute automatically upon connection of the peripheral device to a data source, such as a personal computer. The health check application can diagnose problems and if necessary, repair the problems with the peripheral device, the data source, or both. Examples of problems include corrupted data and indications of software, firmware, and hardware failures or impending failures. In some instances, the health check application can provide a warning of an impending failure. The health check application, after initially executing, can be triggered in various ways to scan again for problems. In addition to finding and repairing problems, the health check application can also attend to maintenance.
    • 外围电子设备包括健康检查应用,其配置为在外围设备连接到数据源(例如个人计算机)时自动执行。 健康检查应用程序可以诊断问题,如有必要,可以修复外围设备,数据源或两者的问题。 问题的例子包括损坏的数据和软件,固件,硬件故障或即将发生的故障的指示。 在某些情况下,健康检查应用程序可以提供即将发生故障的警告。 健康检查应用程序在初始执行后可以通过各种方式触发,以再次扫描问题。 除了查找和修复问题外,健康检查应用程序也可以参加维护。
    • 85. 发明申请
    • Method of preparing microparticles
    • 微粒制备方法
    • US20060166838A1
    • 2006-07-27
    • US10516622
    • 2003-05-15
    • Ian CollinsSimon Duncum
    • Ian CollinsSimon Duncum
    • C09K8/60
    • C09K8/92B01J13/125C09K8/536C09K8/54
    • A method of preparing microparticles comprising an aqueous solution or dispersion of an oil or gas field production chemical encapsulated in a continuous polymeric phase comprising a degradable polymer, which method comprises: (a) preparing a water in oil in water double emulsion or a water in oil in oil double emulsion having an internal aqueous phase comprising an aqueous solution or dispersion of the production chemical and an internal oil phase comprising a solution of a degradable polymer dissolved in a volatile organic solvent wherein the internal aqueous phase is dispersed in the internal oil phase of the double emulsion in the form of droplets having a mean diameter of less than 10 microns; and (b) at least in part evaporating the volatile organic solvent from the double emulsion such that the degradable polymer accumulates around the droplets of the internal aqueous phase and hardens to form microparticles comprising a continuous polymeric phase encapsulating the internal aqueous phase having a mean particle diameter of less than 10 microns.
    • 一种制备微粒的方法,其包括包封在包含可降解聚合物的连续聚合物相中的油或气田生产化学品的水溶液或分散体,该方法包括:(a)在水中制备水包油双乳液或水 油包水乳液,其具有包含生产化学品的水溶液或分散体的内部水相和包含溶解在挥发性有机溶剂中的可降解聚合物溶液的内部油相,其中内部水相分散在内部油相中 的平均直径小于10微米的液滴形式的双重乳液; 和(b)至少部分地从双重乳液中蒸发挥发性有机溶剂,使得可降解聚合物在内部水​​相的液滴周围积聚并硬化以形成包含连续聚合物相的微粒,所述微粒包封具有平均粒子的内部水相 直径小于10微米。
    • 89. 发明授权
    • Quinoxaline-2-carboxamidotetrazoles
    • 喹喔啉-2-甲酰胺基四唑
    • US3997535A
    • 1976-12-14
    • US449992
    • 1974-03-11
    • Ian CollinsGwynn Pennant Ellis
    • Ian CollinsGwynn Pennant Ellis
    • C07D403/12C07D241/44C07D241/00
    • C07D241/44Y10S514/826Y10S514/861
    • Compounds of the general formula I: ##STR1## and pharmaceutically acceptable salts thereof in which: A represents the group ##STR2## or the group ##STR3## linked to the adjacent benzene ring through the nitrogen atom, in which R.sub.1 represents a hydrogen atom, or an alkyl group which may optionally be substituted by one or more aryl, aryloxy, alkoxy, acyloxy, amino, alkylamino, dialkylamino or hydroxy groups or represents an alkenyl group;R.sub.2 represents a hydrogen atom, a halogen atom or an alkyl group or the group OR.sub.3, where R.sub.3 is a hydrogen atom or an alkyl group which may optionally be substituted by one or more aryl, aryloxy, alkoxy, acyloxy, hydroxy, amino, alkylamino or dialkylamino groups or the group NR.sub.4 R.sub.5 where R.sub.4 and R.sub.5 may be the same or different and have the meanings given for R.sub.1 or R.sub.4 and R.sub.5 together with the nitrogen atom form a 5 or 6 membered heterocyclic ring which may optionally contain additional hetero atoms;R.sub.6 and R.sub.7 which may be the same or different represent a hydrogen atom, or a halogen atom or an alkyl group or the group OR.sub.3 or the group NR.sub.4 R.sub.5 as defined above. These compounds have activity as for the treatment of conditions caused primarily by the combination of an antigen with a reaginic antibody.
    • 通式I:Ⅰ的化合物及其药学上可接受的盐,其中: